Advestra advised life sciences startup EvlaBio on its EUR 21 million seed financing round. Headquartered in Zurich, EvlaBio specialises in the development of therapies for Left Ventricular Hypertrophy (LVH) in the context of Chronic Kidney Disease (
Tags :sx3
Kellerhals Carrard advised Tutornow in connection with its acquisition of a 100% stake in Hdemia. The parties Founded in 2021, buyer Tutornow is a startup specialised in digital solutions for education. Established in 2016, selling part Hdemia provides
Affidea completed its investment in b-rayZ as part of a new financing round. In connection with the operation, Kellerhals Carrard advised b-rayZ, while Niederer Kraft Frey supported Affidea. The context Headquartered in Schlieren, Switzerland, medtech
Bratschi appointed Janusz Marty as a partner in Zurich, effective July 1st, 2025. He moves from Burckhardt. The profile A specialist across corporate and contract law, Janusz Marty regularly advises founders, investors and companies on financing
Baker McKenzie Switzerland has promoted Diana Bellido Gomes (pictured) to partnership in Geneva, effective 1 July 2025. Bellido Gomes will bolster the Firm’s Global Reorganizations and Mergers & Acquisitions Practice Groups in the city. Moreover, she
Effective 1 July 2025, Andreas Bohrer will cover the newly created role of Chief Legal & Corporate Affairs Office at Lonza, a Basel-based healthcare manufacturing company. Moreover, Bohrer will become a member of the company’s Executive
As of May 1 2025, Charles Russell Speechlys promoted British lawyer Elena Dunn (pictured) from senior associate to counsel in Zurich. The profile A UK solicitor with over 11 years of experience, Elena Dunn advises an international clientele
On April 1st 2025, Déborah Carlson Burkart (pictured) joined Eversheds Sutherland as the firm’s new Of-Counsel in Bern, moving from Wernli Rechtsanwälte. Burkart’s legal experience spans the areas of corporate law, corporate
As of March 2025, Ferdinand Winter (pictured) has been appointed General Counsel of Ten23 health, a Swiss pharmaceutical contract development and manufacturing organization. Moving from Hansa Biopharma, Sweden, Ferdinand will be responsible for establishing and leading
Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is
